DE60121813D1 - Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten - Google Patents

Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten

Info

Publication number
DE60121813D1
DE60121813D1 DE60121813T DE60121813T DE60121813D1 DE 60121813 D1 DE60121813 D1 DE 60121813D1 DE 60121813 T DE60121813 T DE 60121813T DE 60121813 T DE60121813 T DE 60121813T DE 60121813 D1 DE60121813 D1 DE 60121813D1
Authority
DE
Germany
Prior art keywords
compounds
new
compositions containing
medical compositions
chinuclidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60121813T
Other languages
English (en)
Other versions
DE60121813T2 (de
Inventor
Quinones Maria Prat
Forner Dolors Fernandez
Albero Antonia Buil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Almirall Prodesfarma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Prodesfarma AG filed Critical Almirall Prodesfarma AG
Publication of DE60121813D1 publication Critical patent/DE60121813D1/de
Application granted granted Critical
Publication of DE60121813T2 publication Critical patent/DE60121813T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60121813T 2000-12-28 2001-12-20 Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten Expired - Lifetime DE60121813T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200003130 2000-12-28
ES200003130 2000-12-28
PCT/EP2001/015168 WO2002053564A2 (en) 2000-12-28 2001-12-20 Quinuclidine derivatives and their use as m3 antagonists

Publications (2)

Publication Number Publication Date
DE60121813D1 true DE60121813D1 (de) 2006-09-07
DE60121813T2 DE60121813T2 (de) 2007-09-20

Family

ID=8496180

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60121813T Expired - Lifetime DE60121813T2 (de) 2000-12-28 2001-12-20 Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten

Country Status (34)

Country Link
US (4) US7122558B2 (de)
EP (1) EP1353919B1 (de)
JP (1) JP4295985B2 (de)
KR (1) KR100869721B1 (de)
CN (1) CN1250545C (de)
AR (1) AR032072A1 (de)
AT (1) ATE334128T1 (de)
AU (1) AU2002238471B2 (de)
BG (1) BG66162B1 (de)
BR (1) BR0116624A (de)
CA (1) CA2433128C (de)
CY (1) CY1105719T1 (de)
CZ (1) CZ301209B6 (de)
DE (1) DE60121813T2 (de)
DK (1) DK1353919T3 (de)
EC (1) ECSP034672A (de)
EE (1) EE05404B1 (de)
ES (1) ES2266291T3 (de)
HK (1) HK1055739A1 (de)
HU (1) HUP0303524A3 (de)
IL (2) IL156558A0 (de)
MX (1) MXPA03005862A (de)
MY (1) MY136067A (de)
NO (1) NO328772B1 (de)
NZ (1) NZ526674A (de)
PE (1) PE20020721A1 (de)
PL (1) PL363807A1 (de)
PT (1) PT1353919E (de)
RU (1) RU2282629C2 (de)
SI (1) SI1353919T1 (de)
SK (1) SK287414B6 (de)
UA (1) UA75626C2 (de)
WO (1) WO2002053564A2 (de)
ZA (1) ZA200305008B (de)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
IL156499A0 (en) 2000-12-22 2004-01-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
JP4295985B2 (ja) * 2000-12-28 2009-07-15 ラボラトリオス・アルミラル・ソシエダッド・アノニマ 新規なキヌクリジン誘導体およびそれを含む医薬組成物
GB0118373D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Novel therapeutic method
ES2203327B1 (es) 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
ES2204295B1 (es) 2002-07-02 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de quinuclidina-amida.
JP2006502985A (ja) 2002-07-08 2006-01-26 ランバクシー ラボラトリーズ リミテッド ムスカリン性受容体拮抗剤として有用な３，６−二置換アザビシクロ［３．１．０］ヘキサン誘導体
EP1545508A4 (de) * 2002-08-09 2009-11-25 Ranbaxy Lab Ltd 3,6-disubstituierte azabicyclo ¬3.1.0 hexan-derivate als muscarinische rezeptor-antagonisten
TW200800953A (en) 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
EP1618091A1 (de) 2003-04-09 2006-01-25 Ranbaxy Laboratories, Ltd. Substituierte azabicyclohexanderivate als antagonisten von muscarinrezeptoren
JP2006522787A (ja) * 2003-04-11 2006-10-05 ランバクシー ラボラトリーズ リミテッド ムスカリン様受容体アンタゴニストとしてのアザビシクロ誘導体
AR044134A1 (es) 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
CN100445281C (zh) * 2003-05-02 2008-12-24 诺瓦提斯公司 与毒蕈碱性m3受体结合的奎宁环衍生物
AR044519A1 (es) 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
DE602004021921D1 (de) 2003-05-28 2009-08-20 Theravance Inc Azabicycloalkanverbindungen als muscarinrezeptor antagonisten
JP2007524641A (ja) 2003-07-11 2007-08-30 セラヴァンス， インコーポレーテッド 置換４−アミノ−１−ベンジルピペリジン化合物
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
GB0401334D0 (en) 2004-01-21 2004-02-25 Novartis Ag Organic compounds
ES2239546B1 (es) * 2004-03-15 2006-12-01 Almirall Prodesfarma, S.A. Nuevos esteres de quinuclidina cuaternizados.
MY144753A (en) 2004-04-27 2011-10-31 Glaxo Group Ltd Muscarinic acetylcholine receptor antagonists
EP1747219A4 (de) * 2004-05-13 2010-05-26 Glaxo Group Ltd Antagonisten des muscarinischen acetylcholinrezeptors
GB0411056D0 (en) 2004-05-18 2004-06-23 Novartis Ag Organic compounds
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
DE602005018969D1 (de) * 2004-05-31 2010-03-04 Almirall Sa Zusammensetzungen mit Antimuskarin-Wirkstoffen und Corticosteroiden
WO2006035303A1 (en) * 2004-09-29 2006-04-06 Ranbaxy Laboratories Limited Muscarinic receptor antagonists
GT200500281A (es) 2004-10-22 2006-04-24 Novartis Ag Compuestos organicos.
WO2006047427A1 (en) * 2004-10-25 2006-05-04 Schering Corporation M1 and/or m3 receptor antagonists in combination with other actives for treating respiratory disorders
GB0426164D0 (en) 2004-11-29 2004-12-29 Novartis Ag Organic compounds
GB0507577D0 (en) 2005-04-14 2005-05-18 Novartis Ag Organic compounds
GB0510390D0 (en) 2005-05-20 2005-06-29 Novartis Ag Organic compounds
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
EP2532679B1 (de) 2005-10-21 2017-04-12 Novartis AG Menschliche Antikörper gegen IL13 und therapeutische Verwendungen
GB0601951D0 (en) 2006-01-31 2006-03-15 Novartis Ag Organic compounds
AR060607A1 (es) 2006-04-21 2008-07-02 Novartis Ag Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias.
ES2298049B1 (es) * 2006-07-21 2009-10-20 Laboratorios Almirall S.A. Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
EP2081933B1 (de) 2006-09-29 2011-03-23 Novartis AG Pyrazolopyrimidine als pi3k-lipidkinasehemmer
TW200825084A (en) 2006-11-14 2008-06-16 Astrazeneca Ab New compounds 521
BRPI0720799A2 (pt) 2007-01-10 2014-03-11 Irm Llc Compostos e composições como inibidores de protease de ativação de canal.
CA2678193A1 (en) 2007-02-09 2008-08-14 Astellas Pharma Inc. Aza-bridged-ring compound
UY30916A1 (es) * 2007-02-15 2008-09-30 Argenta Discovery Ltd Derivados del 1-[sustituido]--3-[sustituido]-1-azona-biciclo[2,2,2]octano y sus enantiomeros
BRPI0811562A2 (pt) 2007-05-07 2014-12-09 Novartis Ag Compostos orgânicos
KR101517574B1 (ko) * 2007-09-07 2015-05-07 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 무스카린 수용체 길항제로서 유용한 구아니딘을 함유하는 화합물
CA2608561A1 (en) * 2007-10-29 2009-04-29 Carl Paluszkiewicz Motorcycle wind deflector accessory support
CA2707857C (en) 2007-12-10 2016-09-13 Novartis Ag Spirocyclic amiloride analogues
JP2011506477A (ja) 2007-12-14 2011-03-03 セラヴァンス， インコーポレーテッド ムスカリン受容体拮抗薬として有用なアミジン含有化合物
AU2009203693B2 (en) 2008-01-11 2012-06-07 Novartis Ag Pyrimidines as kinase inhibitors
EP2100599A1 (de) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
EP2100598A1 (de) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalationszusammensetzung enthaltend Aclidinium zur Behandlung von Asthma sowie chronisch-obstruktiver Lungenerkrankung
US8268834B2 (en) 2008-03-19 2012-09-18 Novartis Ag Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
GB0808707D0 (en) * 2008-05-13 2008-06-18 Argenta Discovery Ltd New compounds 275
GB0808708D0 (en) * 2008-05-13 2008-06-18 Astrazeneca Ab New compounds 274
US8329729B2 (en) 2008-05-13 2012-12-11 Astrazeneca Ab Quinuclidine derivatives as muscarinic M3 receptor antagonists
BRPI0915018A2 (pt) 2008-06-10 2015-10-27 Novartis Ag compostos orgânicos
US8263623B2 (en) 2008-07-11 2012-09-11 Pfizer Inc. Triazol derivatives useful for the treatment of diseases
GB0814729D0 (en) * 2008-08-12 2008-09-17 Argenta Discovery Ltd New combination
PL2391366T3 (pl) 2009-01-29 2013-04-30 Novartis Ag Podstawione benzimidazole do leczenia gwiaździaków
US8389526B2 (en) 2009-08-07 2013-03-05 Novartis Ag 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
AU2010283806A1 (en) 2009-08-12 2012-03-01 Novartis Ag Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
EP2467141B1 (de) 2009-08-17 2018-10-31 Intellikine, LLC Heterocyclische verbindungen und ihre verwendung
AU2010284972A1 (en) 2009-08-20 2012-03-08 Novartis Ag Heterocyclic oxime compounds
WO2011050325A1 (en) 2009-10-22 2011-04-28 Vertex Pharmaceuticals Incorporated Compositions for treatment of cystic fibrosis and other chronic diseases
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
EP2386555A1 (de) 2010-05-13 2011-11-16 Almirall, S.A. Neue Cyclohexylaminderivate mit Aktivitäten von Beta2-adrenergem Agonisten und M3-Muskarin-Antagonisten
UY33597A (es) 2010-09-09 2012-04-30 Irm Llc Compuestos y composiciones como inhibidores de la trk
WO2012034095A1 (en) 2010-09-09 2012-03-15 Irm Llc Compounds and compositions as trk inhibitors
US8372845B2 (en) 2010-09-17 2013-02-12 Novartis Ag Pyrazine derivatives as enac blockers
US20130324526A1 (en) 2011-02-10 2013-12-05 Novartis Ag [1,2,4] triazolo [4,3-b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
EP2678016B1 (de) 2011-02-23 2016-08-10 Intellikine, LLC Heterocyclische verbindungen und ihre verwendung
KR20140014184A (ko) 2011-02-25 2014-02-05 아이알엠 엘엘씨 Trk 억제제로서의 화합물 및 조성물
EP2510928A1 (de) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium zur Verbesserung der Schlafqualität bei atemwegserkrankten Patienten
UY34305A (es) 2011-09-01 2013-04-30 Novartis Ag Derivados de heterociclos bicíclicos para el tratamiento de la hipertensión arterial pulmonar
BR112014006223A8 (pt) 2011-09-15 2018-01-09 Novartis Ag 3-(quinolin-6-iltio)-[1,2,4-triazol[4,3-a] piradinas 6-substituídas, seus usos, composições farmacêuticas, e combinação
JP6165733B2 (ja) 2011-09-16 2017-07-19 ノバルティス アーゲー Ｎ−置換ヘテロシクリルカルボキサミド類
US9034879B2 (en) 2011-09-16 2015-05-19 Novartis Ag Heterocyclic compounds for the treatment of CF
WO2013038381A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine/pyrazine amide derivatives
WO2013038373A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
WO2013038378A1 (en) 2011-09-16 2013-03-21 Novartis Ag Pyridine amide derivatives
EP2793893A4 (de) 2011-11-23 2015-07-08 Intellikine Llc Verbesserte behandlungspläne unter verwendung von mtor-inhibitoren
US8809340B2 (en) 2012-03-19 2014-08-19 Novartis Ag Crystalline form
AU2013243097A1 (en) 2012-04-03 2014-10-09 Novartis Ag Combination products with tyrosine kinase inhibitors and their use
US9073921B2 (en) 2013-03-01 2015-07-07 Novartis Ag Salt forms of bicyclic heterocyclic derivatives
JP2016512835A (ja) 2013-03-15 2016-05-09 インテリカイン， エルエルシー キナーゼ阻害剤の組み合わせ及びそれらの使用
JP6218940B2 (ja) * 2013-07-13 2017-10-25 ベイジン エフエスウェルカム テクノロジー ディベロップメント カンパニー リミテッド キニン系化合物、その光学異性体及びその製造方法と医薬用途
WO2015084804A1 (en) 2013-12-03 2015-06-11 Novartis Ag Combination of mdm2 inhibitor and braf inhibitor and their use
MX2016013981A (es) 2014-04-24 2016-11-15 Novartis Ag Derivados de amino-piridina como inhibidores de fosfatidil-inositol-3-cinasa.
JP6433509B2 (ja) 2014-04-24 2018-12-05 ノバルティス アーゲー ホスファチジルイノシトール３−キナーゼ阻害薬としてのアミノピラジン誘導体
US9862711B2 (en) 2014-04-24 2018-01-09 Novartis Ag Pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors
WO2016011658A1 (en) 2014-07-25 2016-01-28 Novartis Ag Combination therapy
ES2831416T3 (es) 2014-07-31 2021-06-08 Novartis Ag Terapia de combinación de un inhibidor de MET y un inhibidor de EGFR
AU2020290094B2 (en) 2019-06-10 2024-01-18 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF, COPD, and bronchiectasis
EP4021572A1 (de) 2019-08-28 2022-07-06 Novartis AG Substituierte 1,3-phenylheteroarylderivate und ihre verwendung zur behandlung von krankheiten
TW202140550A (zh) 2020-01-29 2021-11-01 瑞士商諾華公司 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4465834A (en) * 1965-09-20 1984-08-14 Fmc Corporation Anticholinergic drugs
GB1219606A (en) * 1968-07-15 1971-01-20 Rech S Et D Applic Scient Soge Quinuclidinol derivatives and preparation thereof
US4082756A (en) 1971-04-16 1978-04-04 Colgate-Palmolive Company Quaternary quinuclidinium carbamates and thiocarbamates
WO1981003422A1 (en) * 1980-06-03 1981-12-10 Research Corp Gamma-emitting receptor-binding quinuclidinyl benzilates;methods of preparation thereof and imaging and assay methods utilizing same
US4431627A (en) 1980-06-03 1984-02-14 Research Corporation Gamma-emitting receptor-binding 3-quinuclidinyl glycolates; methods of preparation thereof and imaging and assay methods utilizing same
FR2539135B1 (fr) * 1983-01-11 1986-02-28 Essilor Int Hydrogels de polyurethane et procede de fabrication
IL72788A (en) * 1984-08-28 1989-07-31 Israel State Bis quaternary oxy-bis methylene(or trimethylene)bis-n-quinuclidines,pyridines and piperidines,their preparation and antidotes against organophosphorus and carbamate poisoning containing them
US4644003A (en) * 1985-04-03 1987-02-17 Research Corporation 3-quinuclidinol esters, useful as antagonists of muscarinic acetylcholine receptors
US4675326A (en) * 1985-05-08 1987-06-23 Gabriel Amitai Bisquaternary antidotes
US4843074A (en) * 1988-05-17 1989-06-27 Marion Laboratories, Inc. 1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
IT1230881B (it) * 1989-06-20 1991-11-08 Angeli Inst Spa Derivati del r(-) 3-chinuclidinolo
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
GB8923590D0 (en) 1989-10-19 1989-12-06 Pfizer Ltd Antimuscarinic bronchodilators
WO1992004346A1 (en) 1990-09-06 1992-03-19 Pfizer Limited Antimuscarinic bronchodilators
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
GB9119705D0 (en) 1991-09-14 1991-10-30 Pfizer Ltd Therapeutic compounds
AU685225B2 (en) 1994-02-10 1998-01-15 Yamanouchi Pharmaceutical Co., Ltd. Novel carbamate derivative and medicinal composition containing the same
NO2005012I1 (no) 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
US6130232A (en) 1995-10-13 2000-10-10 Banyu Pharmaceutical Coaltd Substituted piperidine derivatives as muscarinic M3 receptor antagonists
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
US7214687B2 (en) * 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
TR200400420T4 (tr) 2000-06-27 2004-03-22 Laboratorios S.A.L.V.A.T., S.A. Arilalkilaminlerden türetilmiş karbamatlar.
IL156499A0 (en) 2000-12-22 2004-01-04 Almirall Prodesfarma Ag Quinuclidine carbamate derivatives and their use as m3 antagonists
JP4295985B2 (ja) * 2000-12-28 2009-07-15 ラボラトリオス・アルミラル・ソシエダッド・アノニマ 新規なキヌクリジン誘導体およびそれを含む医薬組成物

Also Published As

Publication number Publication date
US20070129398A1 (en) 2007-06-07
EP1353919B1 (de) 2006-07-26
IL156558A (en) 2009-06-15
BG107950A (bg) 2004-03-31
US20100234332A1 (en) 2010-09-16
JP4295985B2 (ja) 2009-07-15
ZA200305008B (en) 2005-01-26
SK7992003A3 (en) 2004-08-03
UA75626C2 (en) 2006-05-15
PL363807A1 (en) 2004-11-29
CY1105719T1 (el) 2010-12-22
US7893087B2 (en) 2011-02-22
PT1353919E (pt) 2006-11-30
ATE334128T1 (de) 2006-08-15
MXPA03005862A (es) 2005-09-08
PE20020721A1 (es) 2002-10-01
ECSP034672A (es) 2003-08-29
ES2266291T3 (es) 2007-03-01
EP1353919A2 (de) 2003-10-22
SK287414B6 (sk) 2010-09-07
NO20033002L (no) 2003-06-30
WO2002053564A2 (en) 2002-07-11
CA2433128A1 (en) 2002-07-11
NO328772B1 (no) 2010-05-10
WO2002053564A3 (en) 2002-10-31
CZ301209B6 (cs) 2009-12-09
NO20033002D0 (no) 2003-06-30
DK1353919T3 (da) 2006-11-20
CN1487938A (zh) 2004-04-07
MY136067A (en) 2008-08-29
BR0116624A (pt) 2003-12-23
US7879874B2 (en) 2011-02-01
EE200300312A (et) 2003-10-15
CA2433128C (en) 2010-05-25
HUP0303524A3 (en) 2008-03-28
CZ20031812A3 (en) 2004-05-12
KR20030067726A (ko) 2003-08-14
BG66162B1 (bg) 2011-09-30
RU2003123120A (ru) 2005-01-10
RU2282629C2 (ru) 2006-08-27
AU2002238471B2 (en) 2007-06-28
AR032072A1 (es) 2003-10-22
HK1055739A1 (en) 2004-01-21
US20070105897A1 (en) 2007-05-10
HUP0303524A2 (hu) 2004-01-28
EE05404B1 (et) 2011-04-15
IL156558A0 (en) 2004-01-04
US7122558B2 (en) 2006-10-17
KR100869721B1 (ko) 2008-11-21
US20040072863A1 (en) 2004-04-15
JP2004517123A (ja) 2004-06-10
NZ526674A (en) 2005-03-24
SI1353919T1 (sl) 2006-12-31
DE60121813T2 (de) 2007-09-20
CN1250545C (zh) 2006-04-12

Similar Documents

Publication Publication Date Title
DE60121813D1 (de) Neue chinuclidinderivate und medizinische zusammensetzungen, die diese verbindungen enthalten
DE60122193D1 (de) Glucopyranosyloxybenzylbenzol derivate und medizinische zusammensetzungen, die diese verbindungen enthalten
ATE267161T1 (de) Phenoxyessigsäure-verbindungen und medizinische zusammensetzungen, die diese enthalten
ATE337311T1 (de) Heterocyclylalkylpiperidinderivate, deren herstellung und zusammensetzungen, die diese derivate enthalten
DE69424173D1 (de) Carbodiimide-Verbindungen und dauerhafte wasserabweisende Zusammensetzungen, die diese Verbindungen enthalten
DE60211532D1 (de) Pastöse zusammensetzung und diese enthaltende kosmetika
ID28695A (id) TURUNAN-TURUNAN BENZO (b) TIEPIN 1,1-DIOKSIDA, PROSES PENYIAPAN, SEDIAAN FARMASI YANG MENGANDUNG SENYAWA-SENYAWA INI, DAN PENGGUNAANNYA
ATE453391T1 (de) Östrogene mittel enthaltende arzneizusammensetzungen
DE60126597D1 (de) 3-stickstoff-6,7-dioxygenierte steroid verbindungen und verwendungen davon
DE69908819D1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
ATE298748T1 (de) (1,4')-bipiperidin verbindungen
DE60209929D1 (de) Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen
DE69916586D1 (de) Indol-derivate und medizinische zusammensetzungen die diese enthalten
DE60006810D1 (de) Dicarboxylato-diamin-platin-derivate und zusammensetzungen die diese als antitumormittel enthalten
DE59900969D1 (de) Neue Diaminobenzol-Derivate und diese Verbindungen enthaltende Färbemittel
DE60012988D1 (en) Taxane mit carbonaten in c-4
EE200200281A (et) Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks
DE602004023623D1 (de) Chirale verbindungen und zusammensetzungen, die diese enthalten
ATE250570T1 (de) Phenylaminoalkylcarbonsäure-derivate und medizinische zusammensetzungen, die diese enthalten
DE60042585D1 (de) 3-Aza-6,8-dioxabicycloÄ3.2.1Üoctane und Analoga sowie diese enthaltende kombinatorische Bibliotheken
DE60013947D1 (de) (Poly)thia-alkin-Verbindungen und ihre Derivate, diese enthaltende Zusammensetzungen und ihre Anwendung
DE60012353D1 (de) Polyorthoester und härtbare zusammensetzung, die diese enthalten
DE60134735D1 (de) Neue neurokinin-antagonisten zum gebrauch als arzneimittel
DE60005517D1 (de) Kaliumkanal-blockierende mittel
ATE221874T1 (de) Hetero-ethynyl-verbindungen und diese enthaltende zusammensetzungen und kosmetika

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: ALMIRALL AG, BAAR, CH

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATORIOS ALMIRALL, S.A., BARCELONA, ES